PolyPid to Report Third Quarter 2022 Financial Results and Operational Highlights on November 9, 2022

Patient and doctor
October 2022

PETACH TIKVA, Israel , Oct. 26, 2022 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its third quarter 2022 financial results and operational highlights before the

Contact Us

    Your information will be processed in accordance with the Privacy Policy.

    Contact icon